Hepatobiliary calculi associated with ceftriaxone treatment: An analysis of FAERS data from 2004 to 2021.

Xin Liu,Ze Xu,Juman Ma,Aijun Zhang,Zhaohang Li,Guanpeng Qi,Zuojing Li, Fenfang Wei, Ling Zhong

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy(2023)

Cited 0|Views3
No score
Abstract
Gender was not detected as a risk factor for HBC caused by ceftriaxone. However, Male infants, male children, female children, adolescent male, and elderly female were potential risk factors for HBC caused by ceftriaxone based on criteria ROR025 > 1 and IC025 > 0.
More
Translated text
Key words
Adverse event reporting system,Ceftriaxone,Cholelithiasis,Disproportionality analysis,Pseudocholelithiasis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined